3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
7
Head & Neck
6
Other hematologic neoplasm
1
Myeloid
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
967
Precursor Cell Lymphoblastic Leukemia-Lymphoma
585
Leukemia, Lymphocytic, Chronic, B-Cell
555
Leukemia
486
Myelodysplastic Syndromes
375
Lymphoma, Non-Hodgkin
347
Lymphoma
297
Lymphoma, Mantle-Cell
263
Hematologic Neoplasms
260
Lymphoma, Follicular
256
Lymphoma, Large B-Cell, Diffuse
253
Burkitt Lymphoma
232
Lymphoma, B-Cell, Marginal Zone
227
Recurrence
216
Hodgkin Disease
182
Multiple Myeloma
172
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
159
Lymphoma, Large-Cell, Immunoblastic
158
Leukemia, Myelomonocytic, Chronic
153
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
147
Waldenstrom Macroglobulinemia
123
Lymphoma, T-Cell, Cutaneous
116
Neoplasms
112
Lymphoma, Large-Cell, Anaplastic
111
Blast Crisis
105
Congenital Abnormalities
104
Immunoblastic Lymphadenopathy
98
Mycosis Fungoides
97
Sezary Syndrome
96
Myeloproliferative Disorders
92
Interventions
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Epstein-Barr Virus Infections
×
Other hematologic neoplasm
×
Clear all
NCT01494103
2025-07-11
DOTTI
Baylor College of Medicine
Phase 1
Active not recruiting
15 enrolled